HOOD vs STRO · P/E 48, rev $4.47B vs rev $62.0M
Robinhood Markets Inc (HOOD) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vlad Tenev.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported HOOD revenue for 2025-12-31 was $4.47B. Net income was $1.88B. Revenue was up 51.6% from 2024-12-31 to 2025-12-31. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
HOOD currently screens at market cap $88.36B and trailing P/E 47.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the HOOD and STRO stock pages for the full models.
Not investment advice.